BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August

Day

• 2
• 3
• 4
• 5
• 6
• 7
• 9
• 10
• 11
• 12
• 13
• 14

• Press Releases

  BridgeBio Pharma Announces Launch of Secondary Offering of Common Stock on Behalf of an Existing Shareholder

  August 14, 2026

   · 

  4 min read
• Press Releases

  Marpai Reports Second Quarter 2026 Financial Results

  August 14, 2026

   · 

  11 min read
• Press Releases

  Longevity Medical Institute® Launches Advanced Intranasal Regenerative Neurological Therapy Platform

  Non-invasive nose-to-brain delivery system expands treatment options for patients with

  August 14, 2026

   · 

  1 min read
• Press Releases

  Gulfstream Intelligence Launches Connected Regulatory Intelligence and Execution Platform for Pharmaceutical and Biotech Teams

  Built by regulatory professionals with more than 25 years of industry experience, Gulfstream Intelligence connects regulatory intelligence, global labeling, gap assessment, health authority preparation, submission planning and regulatory document analysis in one platform.

  August 14, 2026

   · 

  1 min read
• Press Releases

  Zentalis Pharmaceuticals Announces Pricing of Underwritten Public Offering - August 13, 2026

  August 14, 2026

   · 

  4 min read
• Press Releases

  Pfizer and Valneva’s Lyme Disease Vaccine Candidate Marketing Authorization Application Validated by European Medicines Agency

  August 14, 2026

   · 

  12 min read
• Press Releases

  Notice Of Annual General Meeting in Biovica International AB 2026

  August 14, 2026

   · 

  75 min read
• Press Releases

  Innate Pharma Announces Conference Call and Webcast

  August 14, 2026

   · 

  3 min read
• Press Releases

  ALK’s tree pollen and house dust mite tablets now recommended by NICE for paediatric treatment in the UK health system

  August 14, 2026

   · 

  3 min read
• 

  Regulatory

  Pressure piles on Amgen after EU pulls Tavneos, flags ‘serious breaches’ in pivotal study

  Sponsors of the pivotal study behind Amgen’s rare disease drug Tavneos saw unblinded findings for the drug and re-adjudicated data from nine patients to make the drug seem effective, according to European regulators.

  August 14, 2026

   · 

  2 min read

   · 

  Tristan Manalac